Bioequivalence Study of Once Daily PMR Compared to Twice Daily Cilostazol IR Tablets in Healthy Volunteers

Condition:   Intermittent Claudication Interventions:   Drug: Cilostazol 100 mg;   Drug: PMR 200 mg Sponsor:   Genovate Biotechnology Co., Ltd., Active, not recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials